ROYAL BANK OF CANADA - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 140 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$324,000
-87.7%
2,222
-80.5%
0.00%
-100.0%
Q2 2023$2,630,000
-16.3%
11,388
-12.2%
0.00%0.0%
Q1 2023$3,143,000
-17.7%
12,971
-1.4%
0.00%0.0%
Q4 2022$3,817,000
+454.8%
13,150
+24.3%
0.00%
Q3 2022$688,000
-8.4%
10,580
+0.8%
0.00%
Q2 2022$751,000
-31.4%
10,497
-5.8%
0.00%
Q1 2022$1,094,000
-1.4%
11,149
-15.0%
0.00%
Q4 2021$1,110,000
+76.5%
13,110
+66.5%
0.00%
Q3 2021$629,000
-16.2%
7,873
+2.3%
0.00%
Q2 2021$751,000
+1646.5%
7,699
+1997.8%
0.00%
Q1 2021$43,000
+168.8%
367
+154.9%
0.00%
Q4 2020$16,000
+6.7%
144
+14.3%
0.00%
Q3 2020$15,000
+114.3%
126
+106.6%
0.00%
Q2 2020$7,000
+16.7%
61
-32.2%
0.00%
Q1 2020$6,000
-81.8%
90
-74.6%
0.00%
Q4 2019$33,000
+312.5%
355
+285.9%
0.00%
Q3 2019$8,000
-20.0%
920.0%0.00%
Q2 2019$10,000
-33.3%
92
-24.6%
0.00%
Q1 2019$15,0000.0%122
-8.3%
0.00%
Q4 2018$15,000
-81.9%
133
-66.0%
0.00%
Q3 2018$83,000
-96.8%
391
-95.8%
0.00%
-100.0%
Q2 2018$2,598,000
+139.0%
9,291
-0.1%
0.00%
Q1 2018$1,087,000
+26.0%
9,304
-1.0%
0.00%
Q4 2017$863,000
+100.7%
9,401
-1.6%
0.00%
Q3 2017$430,000
+14233.3%
9,553
+5008.6%
0.00%
Q2 2017$3,000
+200.0%
187
+315.6%
0.00%
Q1 2017$1,0000.0%45
+7.1%
0.00%
Q4 2016$1,0000.0%420.0%0.00%
Q3 2016$1,000420.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders